中文
  • ABOUT US
    Welcome Message Mission and Vision Leadership History and Milestones Quick Facts Contact Us
  • CLINICAL RESOURCES
    Clinical Departments Center of Excellences Clinical Activities
    Clinical Trials
    Introduction Work Flow Chart Find A Clinical Trail Research Achievement
    Find a Doctor
  • RESEARCH & EDUCATION
    National Cancer Clinical Research Center
    Research
    Key Labaratories Achievements Find a Researcher
    Education
    Graduate Study International Study Continuing Study
  • TIANJIN CANCER INSTITUTE
    Abouts Us
    Introduction Leadership History
    Research
    Our Researchers Core Facilities and Services Journal of Clinical Oncology
  • NURSING CARE
    Introduction
    Our Team Imoportant Events Honor & Awards Contact Us
    Nursing Activities
    Professional Teams Public Services Compassionate Care Caring for Nurses
    Nursing Teaching
    Clinical Nursing Teaching Postgraduate Tutor
    Nursing Research
    Publications:SCI Papers Research Projects Innovations & Patents Publications:Books
    Survivorship Support
  • INTERNATIONAL COLLABORATION
    International Conferences Oversea Trainings International Patients
  • NEWS RELEASE
Clinical Resources>Clinical Trials>Research Achievement

Introduction

Work Flow Chart

Find a Clinical Trial

Research Achievement

1. Yue D, Xu S, Wang Q, Li X, Shen Y, Zhao H, Chen C, Mao W, Liu W, Liu J, Zhang L, Ma H, Li Q, Yang Y, Liu Y, Chen H, Wang C. Erlotinib versus vinorebine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial. Lancet Respir Med. 2018 Nov; 6(11):863-873.
2. Han B, Li K, Wang Q, Zhang L, Shi J, Wang Z, Cheng Y, He J, Shi Y, Zhao Y, Yu H, Zhao Y, Chen W, Luo Y, Wu L, Wang X, Pirker R, Nan K, Jin F, Dong J, Li B, Sun Y. Effects of anlotinib as a third-line or further treatment on overall survival of patients with advanced non–small cell lung cancer the ALTER0303 phase 3 randomized clinical trial. JAMA Oncol. 2018 Nov 1; 4(11): 1569-1575.
3. Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu Z, Mao W, Xiang J, Han Y, Chen Z, Yang H, Wang J, Pang Q, Zheng X, Yang H, Li T, Lordick F, D'Journo XB, Cerfolio RJ, Korst RJ, Novoa NM, Swanson SJ, Brunelli A, Ismail M, Fernando HC, Zhang X, Li Q, Wang G, Chen B, Mao T, Kong M, Guo X, Lin T, Liu M, Fu J; AME Thoracic Surgery Collaborative Group. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial. J Clin Oncol, 2018 Sep 20; 36(27): 2796-2803.
  • West Huan-Hu Rd, Ti Yuan Bei, Hexi District
    Tianjin, 300060, P.R.China
  • Tel/Fax: 0086-22-23359337
  • Email: info@tjmuch.com
Copyright © 2019 天津肿瘤医院 版权所有 津ICP备05002861号-3